139 related articles for article (PubMed ID: 31348492)
1. Pax7, Pax3 and Mamstr genes are involved in skeletal muscle impaired regeneration of dy2J/dy2J mouse model of Lama2-CMD.
Yanay N; Elbaz M; Konikov-Rozenman J; Elgavish S; Nevo Y; Fellig Y; Rabie M; Mitrani-Rosenbaum S; Nevo Y
Hum Mol Genet; 2019 Oct; 28(20):3369-3390. PubMed ID: 31348492
[TBL] [Abstract][Full Text] [Related]
2. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
Moreira Soares Oliveira B; Durbeej M; Holmberg J
PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
4. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
5. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
[TBL] [Abstract][Full Text] [Related]
6. Targeted expression of heme oxygenase-1 in satellite cells improves skeletal muscle pathology in dystrophic mice.
Florczyk-Soluch U; Polak K; Jelinkova S; Bronisz-Budzyńska I; Sabo R; Bolisetty S; Agarwal A; Werner E; Józkowicz A; Stępniewski J; Szade K; Dulak J
Skelet Muscle; 2024 Jun; 14(1):13. PubMed ID: 38867250
[TBL] [Abstract][Full Text] [Related]
7. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
Pasteuning-Vuhman S; Putker K; Tanganyika-de Winter CL; Boertje-van der Meulen JW; van Vliet L; Overzier M; Plomp JJ; Aartsma-Rus A; van Putten M
PLoS One; 2018; 13(5):e0197388. PubMed ID: 29763467
[TBL] [Abstract][Full Text] [Related]
8. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
9. Lack of PKCθ Promotes Regenerative Ability of Muscle Stem Cells in Chronic Muscle Injury.
Fiore PF; Benedetti A; Sandonà M; Madaro L; De Bardi M; Saccone V; Puri PL; Gargioli C; Lozanoska-Ochser B; Bouché M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023816
[TBL] [Abstract][Full Text] [Related]
10. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
[TBL] [Abstract][Full Text] [Related]
11. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.
Turk R; Sterrenburg E; de Meijer EJ; van Ommen GJ; den Dunnen JT; 't Hoen PA
BMC Genomics; 2005 Jul; 6():98. PubMed ID: 16011810
[TBL] [Abstract][Full Text] [Related]
12. Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression.
Yang Q; Li Y; Zhang X; Chen D
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):407-419. PubMed ID: 29079520
[TBL] [Abstract][Full Text] [Related]
13. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
14. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.
Rayavarapu S; Coley W; Cakir E; Jahnke V; Takeda S; Aoki Y; Grodish-Dressman H; Jaiswal JK; Hoffman EP; Brown KJ; Hathout Y; Nagaraju K
Mol Cell Proteomics; 2013 May; 12(5):1061-73. PubMed ID: 23297347
[TBL] [Abstract][Full Text] [Related]
15. Impaired Regeneration in Dystrophic Muscle-New Target for Therapy.
Yanay N; Rabie M; Nevo Y
Front Mol Neurosci; 2020; 13():69. PubMed ID: 32523512
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways.
McCourt JL; Stearns-Reider KM; Mamsa H; Kannan P; Afsharinia MH; Shu C; Gibbs EM; Shin KM; Kurmangaliyev YZ; Schmitt LR; Hansen KC; Crosbie RH
Skelet Muscle; 2023 Jan; 13(1):1. PubMed ID: 36609344
[TBL] [Abstract][Full Text] [Related]
17. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
Nakayama Y; Nara N; Kawakita Y; Takeshima Y; Arakawa M; Katoh M; Morita S; Iwatsuki K; Tanaka K; Okamoto S; Kitamura T; Seki N; Matsuda R; Matsuo M; Saito K; Hara T
Am J Pathol; 2004 May; 164(5):1773-82. PubMed ID: 15111323
[TBL] [Abstract][Full Text] [Related]
18. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
19. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.
Rooney JE; Gurpur PB; Burkin DJ
Proc Natl Acad Sci U S A; 2009 May; 106(19):7991-6. PubMed ID: 19416897
[TBL] [Abstract][Full Text] [Related]
20. Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle.
Farini A; Sitzia C; Cassinelli L; Colleoni F; Parolini D; Giovanella U; Maciotta S; Colombo A; Meregalli M; Torrente Y
Development; 2016 Feb; 143(4):658-69. PubMed ID: 26884398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
